| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 127,408 shares worth roughly $546K on balance. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $23.73M | -50,000 | |
| CEO | 2.07M | $8.05M | - | |
| Dir | 1.48M | $5.74M | - | |
| CFO | 1.07M | $4.16M | - | |
| Other | 1.04M | $4.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 | Christopher Gibson71 | Chief Executive Officer | Sell | 300,000 | $7.30 | $2,188,950.00 | -56.2% | +1.1% | +16.4% | |
| Feb 22, 2022 | Christopher Gibson71 | Chief Executive Officer | Sell | 100,000 | $10.22 | $1,021,540.00 | -29.9% | -42.9% | -21.9% | |
| Jan 31, 2022 | Christopher Gibson71 | Chief Executive Officer | Sell | 19,858 | $11.73 | $232,964.13 | -45.8% | -44.2% | -29.6% | |
| Jan 14, 2022 | Christopher Gibson71 | Chief Executive Officer | Sell | 341,000 | $13.76 | $4,692,177.31 | -93.6% | -46.0% | -37.0% | |
| Jan 4, 2022 | Blake Borgeson68 | Director | Sell | 9,625 | $18.03 | $173,528.16 | -0.1% | -56.7% | -56.6% | |
| Dec 21, 2021 | Blake Borgeson68 | Director | Sell | 9,625 | $18.75 | $180,478.38 | -0.1% | -65.0% | -59.1% | |
| Dec 16, 2021 | Christopher Gibson71 | Chief Executive Officer | Sell | 200 | $20.01 | $4,001.00 | -0.8% | -62.9% | -52.4% | |
| Dec 16, 2021 | Tina Marriott Larson73 | President and COO | Sell | 2,500 | $18.74 | $46,848.40 | -5.0% | -62.9% | -52.4% | |
| Dec 13, 2021 | Christopher Gibson71 | Chief Executive Officer | Sell | 100 | $20.02 | $2,001.50 | -0.4% | -68.3% | -54.5% | |
| Dec 9, 2021 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 11,750 | $20.13 | $236,562.17 | -33.4% | -59.1% | -54.2% |